Importance Data are lacking on the outcomes of patients with severely reduced left
ventricular ejection fraction (LVEF) who undergo revascularization by percutaneous …

Coronary heart disease is a major risk factor for left ventricular (LV) systolic dysfunction.
However, limited data are available regarding long-term benefits of percutaneous coronary …

Outcome studies of percutaneous coronary intervention (PCI) with conventional balloon
angioplasty have established increased in-hospital and 1-year mortality in patients with left …

Left ventricular (LV) dysfunction and multivessel disease (MVD) have been associated with
greater mortality after ST-segment elevation myocardial infarction. The aim of this study was …

Background The efficacy of coronary artery bypass graft surgery (CABG) and percutaneous
coronary intervention (PCI) in patients with coronary artery disease has been well defined by …

Many patients with systolic dysfunction undergo elective percutaneous coronary intervention
(PCI) despite the unknown risk and limited data supporting its use. Therefore, the aim of this …

Background—Heart failure with reduced ejection fraction caused by ischemic heart disease
is associated with increased morbidity and mortality. It remains unclear whether …

The recently concluded Angina With Extremely Serious Operative Mortality Evaluation
(AWESOME) was a randomized clinical trial of percutaneous coronary intervention versus …

Aims To compare coronary artery bypass grafting (CABG) and percutaneous coronary
intervention (PCI) for treatment of patients with heart failure due to ischaemic heart disease …

Aim To evaluate the impact of left ventricular ejection fraction (LVEF) on 3‐year outcomes in
patients with left main coronary artery disease (LMCAD) undergoing percutaneous coronary …